Welcome to the Wyoming Chapter of the American College of Cardiology
Please join your cardiology colleagues at the ACC Rockies Chapter Meeting in Park City, Utah for updates on ACC affairs, the potential new CV Board, and clinical topics such as Genetic and Sports EP, plus a discussion on the growing role of obesity medications in heart failure, and the first-ever Cardiology State-of-the-State report. There will be many opportunities for networking, as well!. For more information and to register, please visit:
ACC Rockies Chapter Meeting 2025
|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- JACC Publishes Mini-Spotlight Issue on Updated ACHD GuidelineThe latest JACC mini-spotlight issue focuses on the new 2025 ACC/AHA/HRS/ISACHD/SCAI Guideline for the Management of Adults With Congenital Heart Disease (ACHD), which replaces and updates the 2018 recommendations for monitoring, counseling and treating ACHD.
- ACCEL Lite: OCEAN Trial: Antithrombotic Therapy after Successful Catheter Ablation for Atrial FibrillationIn this interview, Thomas F. Deering MD, FACC and Atul Verma, MD FACC discuss the “OCEAN Trial: Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillationâ€.
- How Does Exposure to Fine Particulate Matter Air Pollution Impact CV Mortality, Hospital Admissions?Two studies recently published in JACC explore the relationship between short-term exposure to ambient fine particulate matter (PM2.5) and cardiovascular mortality and the impact of long-term exposure to PM2.5 from wildfire smoke on hospitalizations due to cardiovascular disease.
- Cardiomyopathy Gene Variants Increase Risk of AFibThe genetic variants that cause cardiomyopathy also increase the risk of atrial fibrillation (AFib), even in individuals without heart failure (HF) or overt ventricular disease, according to research published Feb. 18 in JACC.
- Management of Dyslipidemia in People Living With HIV: The REPRIEVE Paradigm in the 2025 ESC/EAS Guidelines Focused UpdateGlobally, an estimated 40.8 million people are living with HIV (PWH). Advances in antiretroviral therapy (ART) have enabled PWH to achieve a near-normal life expectancy; however, individuals taking ART remain at approximately twofold higher risk of developing atherosclerotic cardiovascular disease (ASCVD) ...